Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial

2015 ◽  
Vol 170 (1) ◽  
pp. 110-116 ◽  
Author(s):  
Kevin R. Bainey ◽  
Sherali Rahim ◽  
Krystal Etherington ◽  
Michael L. Rokoss ◽  
Madhu K. Natarajan ◽  
...  
Keyword(s):  
Acute Kidney Injury ◽  
Renal Insufficiency ◽  
Angiotensin Converting Enzyme ◽  
Cardiac Catheterization ◽  
Angiotensin Receptor Blocker ◽  
Enzyme Inhibitor ◽  
Kidney Injury ◽  
Converting Enzyme ◽  
Angiotensin Receptor ◽  
Contrast Induced Nephropathy

scholarly journals Effect of Dual Blockade of Renin-Angiotensin System on Proteinuria

2013 ◽  
Vol 1 (1) ◽  
pp. 18-20
Author(s):  
Eqerem Hasani ◽  
Alma Idrizi ◽  
Myftar Barbullushi
Keyword(s):  
Angiotensin Converting Enzyme ◽  
Angiotensin Receptor Blocker ◽  
Enzyme Inhibitor ◽  
Combined Therapy ◽  
Renin Angiotensin System ◽  
Converting Enzyme ◽  
Angiotensin Receptor ◽  
Angiotensin System ◽  
Renin Angiotensin ◽  
Dual Blockade

Aim: Aim of the study was the evaluation of the effect of dual blockade of the renin-angiotensin system (RAS) on proteinuria. Material and Methods: Sixty patients, included in the study, were treated with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker for a period of 3 months. Results: The dual blockade of RAS resulted with decrease of proteinuria, a slight increase of serum creatinine and was not associated with a lowering of blood pressure.Conclusion: Combined therapy with ACE-I and ARB results in a more complete blockade of the RAS than monotherapy. In proteinuric nephropathies it reduces significantly baseline proteinuria.

Sign in / Sign up

Export Citation Format

Share Document